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There is growing evidence that oxidative stress contributes to the pathogenesis of  anxiety 
disorders. Our aim was to measure oxidative stress in anxiety disorders subjects, and assesses the 
potential confounding influences of anti anxiety therapy. Serum malondialdehyde and antioxidant 
levels were estimated in patients at the time of presentation and also after anti- anxiety therapy for 3 
months. During the period of study no antioxidant/s was given to the patients and control subjects. 
Serum   malondialdehyde   levels   were   significantly  higher   in   the  anxiety disorders  patients   in 
comparison to control cases. Also, the antioxidant activity of enzymes super oxide dismutase, 
glutathione and non enzymatic antioxidant levels of vitamins E and C were significantly lower in 
patients compared to controls at the initial presentation. After 3 months of anti anxiety treatment all 
the above parameters showed reversal in the respective levels of serum malondialdehyde and 
antioxidant activity. Anti anxiety medications results in reduced oxidative stress which indicates that 
oxidative stress is not the cause, but rather a consequence,
 of anxiety disorders.
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Oxidative stress  has  been  implicated in the 
pathogenesis of diverse disease states and may be a 
common pathogenic mechanism underlying many 
major   psychiatric   disorders,   as   the   brain   has 
comparatively   greater   vulnerability   to   oxidative 
damage.   The   current   evidence   for   the   role   of 
oxidative stress in psychiatric disorders, and its 
academic   and   clinical   implication   has   been 
reviewed recently (Ng et al 2008). The broadest 
data for oxidative stress mechanism  have been 
derived from studies conducted in schizophrenia, 
where evidence is available from different areas of 
oxidative   research,   including   oxidative   marker 
assay,   psychopharmacology   studies   and   clinical 
trials of antioxidants. The most common disorder in 
late life is generalized anxiety disorder (GAD), 
which is characterized by >6 months of worry about 
a   number   of   life   domains   (e.g.   relationships, 
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finances and health), difficulty in controlling the 
worry, and associated physical symptoms such as 
restlessness, fatigue, muscle tension and insomnia 
that   interfere   with   social   or   occupational 
functioning. A new onset of GAD among older 
adults is often related to a depressive disorder. The 
combination of major depressive disorder and GAD 
has a worse prognosis overall, requiring 50% more 
time   to   respond   to   treatment   and   incomplete 
recovery from the depression (Ng et al 2008).
Evidence show that free radical attacks to the 
cells in the brain can, over time, impair mental 
acquity. In fact, the brain may bear the brunt of free 
radical attacks since it is rich in fatty acids, a 
favorite   free   radical   target,   and   it   uses   large 
quantities of oxygen- a potential source of free 
radicals (Knight et al 1988). Keeping these facts in 
view, the present study was under taken with the 
objective to find the role of free  radicals  and 
endogenous enzymatic antioxidant in patients of 
anxiety disorders.
We have measured the levels of oxidative stress 
along with the status of antioxidant enzymes in the 
serum of the anxiety patients to assess the influence 
of   anti-  anxiety   medications   in   the   patient   of 
generalized anxiety disorder and also  to assess 
clinico-pathological   correlation   at   the   initial 
presentation and post- treatment.
MATERIALS AND METHODS
The   present   study   includes   50   cases   of 
generalized   anxiety   disorder   selected   from   the 
outpatient Department of Medicine, Sir Sunder Lal 
Hospital, Banaras Hindu University, Varanasi. 20 
healthy individuals matched for age and sex were 
selected as a control group. Patients were subjected 
to Hamilton rating score for anxiety and those who 
were having a >14 score were selected.  All the 
patients were ensured of any previous treatment and 
only those were included who had not received any 
anti-anxiety   or   anti-depressant   treatment.   The 
patients were  subjected to anti-anxiety or anti-
depressant treatment (without antioxidants) for a 
period   of   three   months.   Blood   samples   were 
collected from the ante cubital vein of control 
individuals as well as from  the patients before 
therapy and after treatment for the separation of 
serum.  Informed consent of each participant was 
obtained for induction into purely scientific enquiry 
necessitating blood samples.
Oxidative   stress,   enzymatic   antioxidants   and 
vitamin assay
Serum malondialdehyde levels in the patients 
and control were assayed by thiobarbituric acid 
technique of Philpot, 1963. Assay of super oxide 
dismutase (SOD) was based on the ability of the 
enzyme to inhibit the auto oxidation of pyrogallol 
(Marklund   and   Marklund   1974).   The   enzyme 
inhibition caused by the serum was calculated and 
the   enzyme   activity   was   expressed   in   mg 
protein/ml of serum. Glutathione peroxidase (GSH) 
determination   was   performed   using   Ellman’s 
reagent (Beutler et al 1963). The value of GSH was 
expressed   in   M   of   DTNB   conjugated/mg   of 
protein. Assay of vitamin E was estimated using 
the method of Baker and Frank,  1968. Serum 
ascorbic acid (vitamin C) level was assayed by the 
technique of Mc Murray and Gowenlock, 1988. 
Student's t test was employed for the statistical 
analyses of data to compare each group. The data 
were presented as mean + SEM.
RESULTS 
The   present   study   was   conducted   in  the 
Department of Medicine and Biophysics of Institute of 
Medical Sciences, Banaras Hindu University on the 
selected patients of generalized anxiety disorder 
who   were   subjected   to   anti-anxiety   or   anti-
depressant treatment for a period of three months 
and their results were compared with age and sex 
JOURNAL OF STRESS PHYSIOLOGY & BIOCHEMISTRY Vol. 8 No. 2 2012
34Markers of Oxidative Stress in...
matched healthy controls.  There were 27 (54%) 
males and 23 (46%) females in the anxiety group of 
patients. The general characteristics of the study 
group are outlined in Table I.
Anxiety and tension was the most common 
symptom followed by insomnia, depressed mood 
and   gastrointestinal,   autonomic   cardiovascular, 
somatic, respiratory and genitourinary symptoms. 
Serum   MDA   levels   were   measured   as   the 
marker of the oxidative stress and were observed to 
be significantly raised in anxiety patients at the 
initial presentation in comparison to control cases.
Before the anti- anxiety therapy, elevated levels 
of serum malondialdehyde level in anxiety patients 
in   comparison   to   the   control   cases   were 
accompanied by lower levels of antioxidant enzyme 
activity   of   superoxide   dismutase,   glutathione 
peroxidase and non-enzymatic antioxidant activity 
levels of vitamin E and vitamin C (Table III). Anti- 
anxiety medications for a period of three months to 
the anxiety patients exhibited a reversal trend with 
lower value of serum malondialdehyde along with a 
significant   increase   in   the   values   antioxidant 
enzyme   activity   of   superoxide   dismutase, 
glutathione   peroxidase,   and   non-enzymatic 
antioxidant activity levels of vitamin E and C.
Hamilton anxiety rating score was significantly 
decreased in cases after 3 month of treatment in 
comparison to cases without treatment and this 
difference was statistically highly significant Table 
IV.
Table I. General characteristics of the study group
Variables  Control Patients
Number  20 50
Gender (M/F) 14/6 27/23
Age (years) 56 + 9 58 + 6
Table II. Symptoms in Anxiety patients
Symptoms  No of patients Percentage
Anxious 39 78
Tension  36 72
Fears  13 26
Insomnia 33 66
Intellectual 9 18
Depressed mood 29 58
Somatic (Muscular) 7 14
Somatic (Sensory) 17 34
Cardiovascular  22 44
Respiratory 15 30
Gastrointestinal  27 54
Genitourinary 11 22
Autonomic symptoms  23 46
Behavior at interview  27 54
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Table III. Serum MDA level and antioxidant enzyme activities in control and generalized anxiety 
disorder cases without and with anti- anxiety therapy
Variables Control 
(n=20)
Generalized anxiety disorder (n=50)
Pre-treatment Post-treatment
(after 3 months)
MDA (m Mol/L) 0.21 + 0.53 0.35±0.11 0.23 + 0.06
#
SOD (mg protein/ml of serum) 20.12 + 3.65 6.22±1.27 15.34±4.86
GSH (mM of DTNB conjugated/ml of protein)  0.13 + 0.03 0.05 + 0.01* 0.09 + 0.02
# 
Vitamin E (mg/L) 11.84 + 1.21 9.58 + 1.46* 11.02 + 1.44
#
Vitamin C (mg/dl) 2.12 + 1.81 1.89 + 0.23* 1.97 + 0.24
#
Pre- treatment vs. control * p<0.01, Post – treatment vs. pre-treatment # p<0.01
Table IV. Pre treatment and Post treatment Hamilton anxiety rating score in anxiety disorders cases
Group
Cases  Statistical Significance
Pre treatment Post treatment after 3 
months
‘t’ value 
(Paired) ‘p’ value
Hamilton rating anxiety 
score  35.94±6.99 11.71±3.62 13.56 <0.001
DISCUSSION
Oxidative stress is a condition which modifies 
the normal intracellular balance between oxidant 
substances produced during aerobic metabolism and 
antioxidant  system  processes  which  perform  the 
function   of   neutralization,   putting   a   series   of 
protective mechanisms, of both an enzymatic and 
non-enzymatic nature, in action. Enzymatic systems 
include   superoxide   dismutase   (SOD),   catalase 
(CAT) and glutathione peroxidase (GSH-Px). In 
non-enzymatic   systems,   the   most   important 
molecules are glutathione, alpha-tocopherol (vitamin 
E), ascorbic acid (vitamin C), flavonoids, the phenol 
compounds   and   the   minerals   zinc,   copper   and 
selenium (Halliwell and Gutteridge 2007).
Numerous   physiological   and   pathological 
processes such as ageing, excessive caloric intake, 
infections, inflammatory disorders, environmental 
toxins,  pharmacological   treatments,   emotional   or 
psychological   stress,   ionizing   radiation,   cigarette 
smoke and alcohol increase the bodily concentration 
of oxidizing substances, known as reactive oxygen 
species (ROS) or, more commonly, free radicals. 
These are chemical species which are highly reactive 
owing to the presence of free unpaired electrons. An 
increase in free radicals compromises the delicate 
homeostatic   mechanisms   which   involve 
neurotransmitters, hormones, oxidizing substances 
and numerous other mediators.
Owing to their structure, which is rich in double 
bonds, polyunsaturated fatty acids (PUFAs) render 
cellular membranes vulnerable to damage from free 
radicals, causing peroxidation. The damage induced 
by lipid peroxidation renders the cell unstable, and 
therefore compromises fluidity, permeability, signal 
transduction   and   causes   receptor,   mitochondrial 
DNA and nuclear alterations.
Oxidizing stress from free radicals is one of the 
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factors which contribute to an increase in the speed 
of the cell cycle and consequent premature cell 
death, leading to many degenerative illnesses in the 
central   nervous   system,   as   well   as   psychiatric 
disturbances. Peripheral systems undergo a process 
of atherogenesis and can lead to pathologies in the 
cardiovascular system.
Our study indicates that there is an association 
between   increased   oxidative   stress   and   the 
generalized   anxiety   psychiatric   disorders. 
Morphological, biochemical and molecular studies 
both in experimental animals and in human beings 
also reveal that oxidative stress plays a primary role 
in the development of degenerative changes in the 
cells and tissues of our body. The highest degree of 
oxidative   damage   usually  occurs   in   organs   like 
brain, heart and skeleton muscle since these organs 
are composed primarily of post- mitotic cells (Sohal 
and Weindruch 1996). The central nervous system 
shows increased susceptibility to oxidative stress 
because of its high consumption rate (20% of the 
total oxygen inhaled by the body) that accounts for 
the increased generation of oxygen free radicals and 
reactive oxygen substrates. Since all the cells and 
tissues of our body are also equipped with anti 
oxidative   enzymes   like   super   oxide   dismutase 
(SOD),   glutathione   peroxidase   (GPX),glutathione 
reductase   (GRd)   and   substances   like   reduced 
glutathione (GSH), they dispose the free radicals as 
and when they are generated thereby protecting the 
cells and tissues from the oxidative attack. Normally 
a balance is maintained between the oxidative attack 
of the free radicals and the antioxidative defense 
system prevailing in the cells and tissues of body. 
But when the balance is tilted more towards the 
generation   of   free   radicals,   then   degenerative 
changes cause many degenerative diseases. Brain 
has a low level of antioxidative defense system as 
the concentration of various antioxidative enzymes 
like SOD, GPX, GRd and catalase is low in brain 
(Savolainen 1978). In addition brain has a high iron 
and   ascorbate  content   in  certain   regions,   which 
provide favorable environment  for generation of 
oxygen free radicals. Brain is also enriched with 
polyunsaturated fatty acids that render neuronal cells 
easily vulnerable to oxidative attack. The interplay 
of   all   these   factors   contributes   to   enhance   the 
oxidative stress (Zhang et al 1993)
CONCLUSION
Patients with generalized anxiety disorder had 
higher level of MDA and lower levels of SOD, 
glutathione,   Vitamin   E   and   Vitamin   C   before 
therapy and showed reversal of values following 
treatment over a period of three months thereby 
suggest an association between increased oxidative 
stress and the generalized anxiety disorders.
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